1.Borneol is an inducer of rat hepatic CYP2D activity in vivo.
Jing-ya CHEN ; Jun-jun WANG ; Mo-ran MENG ; Yong CHEN
Acta Pharmaceutica Sinica 2015;50(4):459-463
Borneol is a traditional Chinese medicine. In the past few years, many studies showed that borneol can improve the bioavailability of other drugs, promoting drugs to cross the blood-brain barrier, so the potential drug interactions between borneol and other medicines have attracted great attention, but the influence of borneol to CYP450 and its isoforms are rarely reported. In this research, male Wistar rats were orally administered by borneol for 7 days, then the mRNA and protein expression and the activities of CYP2D were detected, we also compared the pharmacokinetic parameters of CYP2D's specific substrate between control group and borneol group. The results show that borneol (33, 100 and 300 mg x kg(-1) x d(-1)) have no significant effect on CYP2D, while the activites of CYP2D increased 1.71, 1.97 and 2.89 times comparing to the control group. At the same time, borneol (300 mg x kg(-1) x d(-1)) caused the C(max) decreased 10.6% (P > 0.05), AUC(0-∞) decreased 27.5% (P < 0.01), CL/F increased 41.1% (P < 0.01), V(z)/F increased 23.1% (P > 0.05) of dextromethorphan. Our data provided that borneol speed up dextromethorphan's elimination in vivo. Since the activity of CYP2D can be induced by borneol, the metabolic interactions might happen when borneol and the substrate drug CYP2D are used together.
Animals
;
Aryl Hydrocarbon Hydroxylases
;
metabolism
;
Blood-Brain Barrier
;
Bornanes
;
pharmacology
;
Cytochrome P-450 Enzyme Inducers
;
pharmacology
;
Dextromethorphan
;
Drug Interactions
;
Liver
;
drug effects
;
enzymology
;
Male
;
Medicine, Chinese Traditional
;
RNA, Messenger
;
Rats
;
Rats, Wistar
2.Genetic variation of S1 gene hypervariable region I of infectious bronchitis viruses isolated in different periods in Guangxi.
Zheng-Ji WEI ; Ping WEI ; Mei-Lan MO ; Meng LI ; Tian-Chao WEI ; Kang-Ran LI
Chinese Journal of Virology 2008;24(2):126-132
The S1 gene hypervariable region I (HVR I) of 22 infectious bronchitis virus (IBV) strains isolated in Guangxi during the period of 1985-2007 were sequenced and compared to that of the other IBV reference strains and the pigeon coronavirus isolates. A phylogenetic tree based on nucleotide sequences of HVR I of all the IBV showed that they were classified into 5 distinct Clusters. 16 out of 22 IBV isolates were grouped into Cluster I, and had higher homology with pigeon coronavirus isolates but lower homology with the Massachusetts (Mass) type vaccine strains. There were 4 and 3 amino-acid residues inserted at the sites of 33-34 and 34-35 respectively within HVR I in 15 isolates, except in isolate GX-NN6 there had 4 amino-acid residues inserted at the both sites; isolates GX-YL1 and GX-NN2 had close relationship with Mass type vaccine strains, and they shared Cluster II; isolates GX-G and GX-XD of Cluster III had close relationship with the Japanese strain JP Miyazaki 89 which was isolated at the same period; isolates GX-YL6 and GX-NN7 of Cluster V had close relationship with the European strain 4/91. The results showed that there were high phylogenetic diversity among the IBVs prevailed in the field in Guangxi resulting from the commonly occurred mutation or insertion within the S1 gene HVR I of the viruses, and majority of the isolates had lower homology with the commonly used Mass type vaccine strains. There was much higher homology among viruses isolated in the same period of time, but without distinct difference in geographical origins.
Amino Acid Sequence
;
Animals
;
Chickens
;
virology
;
Genetic Variation
;
Infectious bronchitis virus
;
classification
;
genetics
;
isolation & purification
;
Membrane Glycoproteins
;
chemistry
;
genetics
;
Molecular Sequence Data
;
Phylogeny
;
Spike Glycoprotein, Coronavirus
;
Viral Envelope Proteins
;
chemistry
;
genetics
3.Recent progress in targeted drug delivery nanosystems for pancreatic cancer treatment
Meng-ru LI ; Teng LI ; Ran MO
Acta Pharmaceutica Sinica 2018;53(7):1090-1099
Pancreatic cancer is a highly-malignant digestive system neoplasm. The anticancer efficacies of the chemotherapeutic drugs for pancreatic cancer treatment, such as gemcitabine, are greatly limited by their poor targetability to tumor and low drug concentration in the tumor tissue. Drug delivery system plays an important role in improvement of therapeutic efficacy and reduction of adverse effects. Enhancement of the tumor targeting capacity of nanomedicine and promotion of the delivery efficiency are the key issues in the research field of pharmaceutics. In this review article, we survey recent progress in targeted drug delivery nanosystems for treatment of pancreatic cancer by targeting cancer cells, pancreatic tumor stroma, pancreatic cancer-associated cells, and pancreatic cancer stem-like cells, which will provide a new insight into clinical treatment of pancreatic cancer.
4.Mutations in CERS3 Gene Underlies a Case of Autosomal Recessive Congenital Ichthyosis
Juan LIU ; Ran MO ; Yihe LIU ; Xin HUANG ; Meng GAO ; Yong YANG ; Zhiming CHEN
JOURNAL OF RARE DISEASES 2023;2(2):290-293
Autosomal recessive congenital ichthyosis caused by CERS3 mutations is extremely rare in clinical practice. We recently identified a family of autosomal recessive congenital ichthyosis and performed multigene exome sequencing for hereditary skin diseases to identify causative genes. Mutation analysis revealed compound heterozygous mutations of c.746A>G(from the mother) and exon12 deletion(from the father)in CERS3 were detected in the proband, which were verified by Sanger sequencing and co-segregated with the ichthyosis phenotype in the proband and her parents. These mutations were both reported for the first time. For the treatment, the proband received an oral acitretin capsules of 20 mg once daily. After 3-month follow up, the patient's lesion improved significantly.